BioSolveIT wins Evotec to search the molecular universe for better drug candidates

May 17, 2016 17:00

St. Augustin, Germany, May 17th 2016 – Today, we announce a strategic partnership with Evotec AG (“Evotec”) to create an immeasurably large molecular search space. The database, so-called ‘EVOspace’ will act as a gigantic “pool” of virtual molecules from which to mine novel, synthetically accessible molecular entities for drug research.

Read the full press release here.

Zealand & BioSolveIT create new therapeutic peptide drug design and development tool

March 18, 2016 12:31

March 14, 2016 – Zealand and BioSolveIT create unique software tool, adding new dimensions to peptide drug design and development.

  • Combining Zealand’s expertise in peptide design and its extensive
    knowledge database with BiosolveIT’s chemical informatics software
  • The tool, which is named PepSee, will help Zealand accelerate peptide
    design with the potential to support innovation and push the
    boundaries of peptide research
  • The collaboration is in line with Zealand’s strategy to enhance its
    leading position in the field of peptide-based medicines

The full press release is here.

SeeSAR’s 3D comes to Optibrium’s StarDrop

March 11, 2016 11:47

Optibrium announces next version with SeeSAR integration.

The next step in the outstanding collaboration between Optibrium and BioSolveIT is announced:

A new, seamless link between 2D and 3D structure-activity relationships guides more efficient
compound optimisation in StarDrop. The high speed and appealing 3D visualization plus analysis functions from SeeSAR, every chemist’s SAR assistant, are now integrated in Optibrium’s powerful ADME suite.

Read the full press release, and stay with us for more outcomes of our joint efforts.

BioSolveIT and Optibrium™ sign collaboration agreement

October 13, 2015 10:05

Breaking News: BioSolveIT and Optibrium signed a collaboration agreement. The partnership will deliver a link between 2D and 3D design on medicinal chemists’ desktops.

The synergies between ADME/Tox experts Optibrium and BioSolveIT will be of huge benefit for researchers in Medicinal Chemistry!

Read the full joint press release here.

Scroll Up